Issue navigation
Volume 40, Issue 3, March 2025
Editorials
Celebrating the life and scientific contributions of Barry Brenner in nephrology
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 409–411, https://doi.org/10.1093/ndt/gfae206
Does amino acid infusion improve kidney outcomes in patients at high risk for postsurgical AKI?
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 412–414, https://doi.org/10.1093/ndt/gfae183
Women of European Renal Association (WERA) task force: together for more awareness towards gender balance in nephrology
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 415–418, https://doi.org/10.1093/ndt/gfae190
Proactively boosting home dialysis adoption in Europe
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 419–422, https://doi.org/10.1093/ndt/gfae199
Reviews
The microbiome and acute organ injury: focus on kidneys
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 423–434, https://doi.org/10.1093/ndt/gfae196
Biology of calcium homeostasis regulation in intestine and kidney
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 435–445, https://doi.org/10.1093/ndt/gfae204
Oxygen sensing in the kidney
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 446–454, https://doi.org/10.1093/ndt/gfae225
Special Report
Ethical considerations on the use of big data and artificial intelligence in kidney research from the ERA ethics committee
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 455–464, https://doi.org/10.1093/ndt/gfae267
Original Articles
Albuminuria predicts kidney events in IgA nephropathy
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 465–474, https://doi.org/10.1093/ndt/gfae085
Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 475–483, https://doi.org/10.1093/ndt/gfae108
Trends and socioeconomic inequality of the burden of congenital abnormalities of the kidney and urinary tract among children and adolescents
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 484–494, https://doi.org/10.1093/ndt/gfae115
Kidney outcomes with SGLT2 inhibitor versus DPP4 inhibitor use in older adults with diabetes
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 495–504, https://doi.org/10.1093/ndt/gfae158
IgA class-switched CD27−CD21+ B cells in IgA nephropathy
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 505–515, https://doi.org/10.1093/ndt/gfae173
Diabetic status and the performances of creatinine- and cystatin C–based eGFR equations
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 516–523, https://doi.org/10.1093/ndt/gfae161
A novel real-time model for predicting acute kidney injury in critically ill patients within 12 hours
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 524–536, https://doi.org/10.1093/ndt/gfae168
A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 537–543, https://doi.org/10.1093/ndt/gfae155
Population-wide eGFR percentiles in younger adults and clinical outcomes
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 544–553, https://doi.org/10.1093/ndt/gfae157
Prognostic impact of post-transplant diabetes mellitus in kidney allograft recipients: a meta-analysis
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 554–576, https://doi.org/10.1093/ndt/gfae185
Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 577–587, https://doi.org/10.1093/ndt/gfae186
Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 588–597, https://doi.org/10.1093/ndt/gfae188
Research Letter
Prospective validation of initial eculizumab dosing in adults with atypical hemolytic uremic syndrome
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 598–601, https://doi.org/10.1093/ndt/gfae244
Biomarker-guided infliximab therapy for immune checkpoint inhibitor-induced acute interstitial nephritis
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Pages 602–604, https://doi.org/10.1093/ndt/gfae257
Corrections
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Page 605, https://doi.org/10.1093/ndt/gfae072
Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis
Nephrology Dialysis Transplantation, Volume 40, Issue 3, March 2025, Page 606, https://doi.org/10.1093/ndt/gfae073
